Thermo Fisher Scientific (TMO) Reports In-Line Q1 EPS
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $603.18 -0.41%
Revenue Growth %: +7.5%
Financial Fact:
Other Expense, Net: -113.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +7.5%
Financial Fact:
Other Expense, Net: -113.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $5.03, in-line with the analyst estimate of $5.03. Revenue for the quarter came in at $10.71 billion versus the consensus estimate of $10.65 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Copart to buy ACV for $1.9 billion in cash deal
- Champions Oncology (CSBR) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
